By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioReliance Corporation 

14920 Broschart Road

Rockville  Maryland  20850  U.S.A.
Phone: 800-553-5372 Fax: 301-610-2590


BioReliance is the leading provider of GLP and cGMP compliant contract services supporting testing, development and manufacturing of biologics worldwide. Founded in 1947 as Microbiological Associates, BioReliance has operations in the United States, United Kingdom and Germany.

Products and services:
BioReliance testing services include: characterization of cell banks, release testing of bulk and final product, viral and DNA clearance studies, analytical services, genetic, mammalian and molecular toxicology, biodistribution studies and comprehensive testing for laboratory animals including serology and PCR testing on rodent and simian species.

BioReliance offers contract manufacturing services for mammalian cell derived viral therapeutics and agents expressed in E.coli and yeast. A full range of services is offered from process development, scale-up and qualification, bulk drug production, aseptic filling and final drug packaging. Regulatory support services include the preparation of Chemistry Manufacturing and Controls (CMC) sections of regulatory filings.

Last Updated: 05-01-2007

Key Statistics

Ownership: Private

Web Site: BioReliance Corporation
Employees: 600+

Company News
BioReliance Corporation Licenses B-CLEAR Technology From Qualyst, Inc. Transporter Solutions For Drug Transporter Studies 4/21/2015 10:22:06 AM
Conatus Pharmaceuticals Inc. And BioReliance Corporation Present Key Emricasan Preclinical Safety Results At Society Of Toxicology Annual Meeting 3/24/2015 7:53:04 AM
BioReliance Corporation Introduces Advanced In Vitro ADME And Toxicology Services Designed To Improve Drug Safety And Efficacy 10/16/2014 7:36:34 AM
Sigma-Aldrich Corporation (SIAL) Release: BioReliance Corporation Opens New U.S. Clearance Services Laboratories; Completes Global Facility Upgrade Plan 9/4/2013 9:43:40 AM
Archie Cullen Named President of BioReliance Corporation 3/5/2013 6:38:55 AM
Sigma-Aldrich Corporation (SIAL) Completes Acquisition of BioReliance Corporation 2/1/2012 10:24:30 AM
Sigma-Aldrich Corporation (SIAL) to Acquire BioReliance Corporation for $350 Million Cash 1/9/2012 7:39:09 AM
BioReliance Corporation Enhances Toxicology Expertise 9/13/2011 11:02:01 AM
BioReliance Corporation Announces ToxCast Award 8/4/2011 9:57:28 AM
Marilyn J. Aardema, PhD Joins BioReliance Corporation as Chief Scientific Officer, Toxicology 11/15/2010 11:26:44 AM